Meta-analyses of FibroTest diagnostic value in chronic liver disease
Open Access
- 15 October 2007
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 7 (1) , 40
- https://doi.org/10.1186/1471-230x-7-40
Abstract
FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC).Keywords
This publication has 55 references indexed in Scilit:
- Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virusJournal of Viral Hepatitis, 2009
- Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- Performance of serum marker panels for liver fibrosis in chronic hepatitis CJournal of Hepatology, 2006
- The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver diseaseJournal of Hepatology, 2006
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- CYP2E1: from ASH to NASHHepatology Research, 2003
- Respective roles of porto‐septal fibrosis and centrilobular fibrosis in alcoholic liver diseaseThe Journal of Pathology, 2003
- Role of liver biopsy in management of chronic hepatitis C: A systematic reviewHepatology, 2002
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996